Susquehanna International Group
VIR icon

Susquehanna International Group’s Vir Biotechnology VIR Stock Holding History

Susquehanna International Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03M Buy
114,700
+74,200
+183% +$591K ﹤0.01% 7818
2025
Q4 		$244K Buy
40,500
+11,500
+40% +$68.5K ﹤0.01% 10428
2025
Q3 		$166K Buy
29,000
+13,800
+91% +$70.6K ﹤0.01% 11183
2025
Q2 		$76.6K Sell
15,200
-119,500
-89% -$641K ﹤0.01% 11932
2025
Q1 		$873K Sell
134,700
-1,000
-0.7% -$8.89K ﹤0.01% 7589
2024
Q4 		$996K Buy
135,700
+62,600
+86% +$494K ﹤0.01% 6945
2024
Q3 		$548K Sell
73,100
-37,600
-34% -$327K ﹤0.01% 8248
2024
Q2 		$985K Sell
110,700
-25,200
-19% -$242K ﹤0.01% 6630
2024
Q1 		$1.38M Buy
135,900
+98,100
+260% +$999K ﹤0.01% 6196
2023
Q4 		$380K Buy
37,800
+9,900
+35% +$90.5K ﹤0.01% 9309
2023
Q3 		$261K Sell
27,900
-246,400
-90% -$3.51M ﹤0.01% 9657
2023
Q2 		$6.73M Buy
274,300
+166,000
+153% +$4.17M ﹤0.01% 3059
2023
Q1 		$2.52M Buy
108,300
+70,300
+185% +$1.8M ﹤0.01% 4668
2022
Q4 		$962K Sell
38,000
-71,500
-65% -$1.75M ﹤0.01% 6281
2022
Q3 		$2.11M Sell
109,500
-21,200
-16% -$539K ﹤0.01% 4809
2022
Q2 		$3.33M Sell
130,700
-40,900
-24% -$955K ﹤0.01% 3885
2022
Q1 		$4.41M Buy
171,600
+33,800
+25% +$1M ﹤0.01% 3848
2021
Q4 		$5.77M Buy
137,800
+13,600
+11% +$533K ﹤0.01% 3507
2021
Q3 		$5.41M Sell
124,200
-22,600
-15% -$978K ﹤0.01% 3816
2021
Q2 		$6.94M Buy
146,800
+44,800
+44% +$2.04M ﹤0.01% 3445
2021
Q1 		$5.23M Sell
102,000
-15,000
-13% -$808K ﹤0.01% 3830
2020
Q4 		$3.13M Buy
117,000
+55,800
+91% +$1.81M ﹤0.01% 4233
2020
Q3 		$2.1M Sell
61,200
-88,500
-59% -$3.81M ﹤0.01% 4525
2020
Q2 		$6.13M Buy
149,700
+140,100
+1,459% +$4.7M ﹤0.01% 2732
2020
Q1 		$329K Buy
+9,600
New +$258K ﹤0.01% 7805

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Susquehanna International Group's VIR Position: Q1 2026 in Review

Susquehanna International Group reduced its Vir Biotechnology (VIR) stake by 50% in Q1 2026, selling an estimated $1.55M and leaving 195,561 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #6477.

Susquehanna International Group first reported a position in VIR in Q1 2020 and has held it in 25 quarters since. The position peaked at $8.8M in Q1 2022. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Susquehanna International Group held 195,561 shares of Vir Biotechnology worth $1.75M as of Q1 2026.
  • Susquehanna International Group sold 194,497 Vir Biotechnology shares in Q1 2026, an estimated $1.55M.
  • Vir Biotechnology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6477 holding.
  • Susquehanna International Group first reported a position in Vir Biotechnology in Q1 2020 and has held it in 25 quarters since.
  • Susquehanna International Group's Vir Biotechnology position peaked at $8.8M in Q1 2022.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.